Tower Research Capital LLC (Trc) Opgen Inc Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.12 - $62.0 $329 - $170,314	-2,747 Reduced 13.25%	17,983 $3,000
Q3 2022 Nov 10, 2022	BUY	$0.39 - $78.8 $339 - $68,556	870 Added 4.38%	20,730 $6,000
Q2 2022 Aug 15, 2022	BUY	$0.32 - $0.79 $5,104 - $12,600	15,950 Added 407.93%	19,860 $11,000
Q1 2022 May 12, 2022	BUY	$0.72 - $1.11 $2,633 - $4,060	3,658 Added 1451.59%	3,910 $3,000
Q4 2021 Feb 14, 2022	SELL	$1.0 - $2.94 $22,597 - $66,435	-22,597 Reduced 98.9%	252 $0
Q3 2021 Nov 15, 2021	BUY	$2.18 - $3.58 $46,178 - $75,835	21,183 Added 1271.49%	22,849 $65,000
Q2 2021 Aug 16, 2021	SELL	$1.95 - $2.8 $11,337 - $16,279	-5,814 Reduced 77.73%	1,666 $3,000
Q1 2021 May 17, 2021	BUY	$1.8 - $3.55 $13,464 - $26,554	7,480 New	7,480 $19,000
Q4 2020 Feb 16, 2021	SELL	$1.7 - $2.47 $1,978 - $2,875	-1,164 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.98 - $3.37 $2,304 - $3,922	1,164 New	1,164 $2,000

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $38.7M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.